Meiji Yasuda Life Insurance Co Reduces Position in Celsius Holdings Inc. $CELH

Meiji Yasuda Life Insurance Co lessened its stake in shares of Celsius Holdings Inc. (NASDAQ:CELH) by 4.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,512 shares of the company’s stock after selling 388 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Celsius were worth $303,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Westside Investment Management Inc. purchased a new stake in Celsius during the 1st quarter worth approximately $32,000. Summit Securities Group LLC purchased a new stake in Celsius during the 1st quarter worth approximately $34,000. MassMutual Private Wealth & Trust FSB grew its position in Celsius by 255.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company’s stock worth $37,000 after purchasing an additional 750 shares during the last quarter. UMB Bank n.a. grew its position in Celsius by 145.0% during the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company’s stock worth $51,000 after purchasing an additional 844 shares during the last quarter. Finally, Fifth Third Bancorp grew its position in Celsius by 62.9% during the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company’s stock worth $61,000 after purchasing an additional 666 shares during the last quarter. Hedge funds and other institutional investors own 60.95% of the company’s stock.

Celsius Stock Performance

CELH opened at $55.64 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The firm has a fifty day moving average price of $51.50 and a 200 day moving average price of $41.40. Celsius Holdings Inc. has a 1 year low of $21.10 and a 1 year high of $63.50. The stock has a market cap of $14.35 billion, a P/E ratio of 150.38, a P/E/G ratio of 1.32 and a beta of 1.33.

Celsius (NASDAQ:CELH) last posted its earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million during the quarter, compared to analysts’ expectations of $632.13 million. During the same period in the previous year, the business posted $0.28 EPS. The business’s revenue was up 83.9% compared to the same quarter last year. Equities research analysts anticipate that Celsius Holdings Inc. will post 0.89 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CELH. Needham & Company LLC upped their price objective on shares of Celsius from $60.00 to $70.00 and gave the company a “buy” rating in a report on Friday. Jefferies Financial Group set a $72.00 price objective on shares of Celsius in a report on Wednesday, September 3rd. Wells Fargo & Company upped their price objective on shares of Celsius from $44.00 to $45.00 and gave the company an “overweight” rating in a report on Wednesday, June 4th. UBS Group upped their price objective on shares of Celsius from $64.00 to $73.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. Finally, Morgan Stanley upped their price objective on shares of Celsius from $56.00 to $61.00 and gave the company an “equal weight” rating in a report on Tuesday, September 2nd. Seventeen analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Celsius currently has an average rating of “Moderate Buy” and an average target price of $61.42.

Insider Transactions at Celsius

In related news, insider Paul H. Storey sold 7,500 shares of the business’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total value of $456,975.00. Following the completion of the transaction, the insider directly owned 37,550 shares in the company, valued at $2,287,921.50. The trade was a 16.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO John Fieldly sold 143,167 shares of the business’s stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the completion of the transaction, the chief executive officer owned 895,410 shares of the company’s stock, valued at approximately $45,827,083.80. This represents a 13.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 991,470 shares of company stock worth $47,307,297. Insiders own 2.20% of the company’s stock.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.